NYLIM
MORF

New York Life Investment Management’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

New York Life Investment Management’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,126
Closed -$378K – 1427
2022
Q4 		$378K Buy
14,126
+1,591
+13% +$43.5K ﹤0.01% 1067
2022
Q3 		$355K Buy
12,535
+920
+8% +$25.6K ﹤0.01% 1031
2022
Q2 		$252K Buy
+11,615
New +$324K ﹤0.01% 1200

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

New York Life Investment Management's MORF Position: Q1 2023 in Review

New York Life Investment Management sold out of Morphic Holding, Inc. Common Stock (MORF) in Q1 2023, closing a stake of 14,126 shares — an estimated $378K sold.

New York Life Investment Management first reported a position in MORF in Q2 2022 and held it in 3 quarters. The position peaked at $378K in Q4 2022. 129 funds tracked by Wall St. Rank hold MORF as of Q1 2023.

  • New York Life Investment Management reported no remaining Morphic Holding, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 14,126 Morphic Holding, Inc. Common Stock shares in Q1 2023, an estimated $378K.
  • New York Life Investment Management first reported a position in Morphic Holding, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • New York Life Investment Management's Morphic Holding, Inc. Common Stock position peaked at $378K in Q4 2022.
  • 129 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.